Enhanced in vitro virus expression using 3-dimensional cell culture spheroids for infection.


Journal

Journal of virological methods
ISSN: 1879-0984
Titre abrégé: J Virol Methods
Pays: Netherlands
ID NLM: 8005839

Informations de publication

Date de publication:
03 2019
Historique:
received: 18 04 2018
revised: 29 08 2018
accepted: 20 12 2018
pubmed: 26 12 2018
medline: 16 4 2019
entrez: 25 12 2018
Statut: ppublish

Résumé

The way viruses interact with cultured cells and their surrounding environment is still a matter of debate. From a technical point of view, 2D cell cultures only partially exhibit the morpho-molecular pattern required for viral tropism, not reflecting the complexity of the microenvironment in vivo. Therefore, 3D cell cultures are envisioned as an alternative approach to study viral replication possibly closer to in vivo conditions than 2D, representing the link between traditional cell culture and in vivo models. The use of cellular spheroids is proving to be useful to optimize and overcome constraints related to conventional in vitro systems for viral isolation. In order to create an advanced 3D in vitro isolation system, we compared the classic 2D shell vial system with the spheroid culture method based on the adhesion inhibition technique with pHema. In this study, we evaluated which of the most common viral cell lines used in our laboratory (A-549, 293 T, CaCo2, KB, HUH-7, VERO, and MRC-5) (Fig. 1) could be grown as 3D cultures and all proved to be able to grow as spheroids. Subsequently, we compared the sensitivity and efficiency of isolation of three viral species of medical interest (Adenovirus, CMV, HSV-1) in 2D and 3D cell cultures obtained from the respective susceptible cells. Our results indicate earlier and more sensitive virus isolation than in traditional 2D shell vial system for all three viruses tested, thus confirming how the establishment of 3D culture systems in the virological field is crucial to the improvement and evolution of more accurate and faster virus isolation protocols.

Identifiants

pubmed: 30582939
pii: S0166-0934(18)30149-6
doi: 10.1016/j.jviromet.2018.12.017
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

99-104

Informations de copyright

Copyright © 2018. Published by Elsevier B.V.

Auteurs

Alfredo Rosellini (A)

Virology Unit, Pisa University Hospital, Pisa, Italy.

Giulia Freer (G)

Retrovirus Center and Virology Section, Department of Translational Medicine, University of Pisa, Via del Brennero 2, I-56127 Pisa, Italy. Electronic address: giulia.freer@med.unipi.it.

Paola Quaranta (P)

Retrovirus Center and Virology Section, Department of Translational Medicine, University of Pisa, Via del Brennero 2, I-56127 Pisa, Italy.

Veronica Dovere (V)

Virology Unit, Pisa University Hospital, Pisa, Italy; Retrovirus Center and Virology Section, Department of Translational Medicine, University of Pisa, Via del Brennero 2, I-56127 Pisa, Italy.

Melissa Menichini (M)

Virology Unit, Pisa University Hospital, Pisa, Italy; Retrovirus Center and Virology Section, Department of Translational Medicine, University of Pisa, Via del Brennero 2, I-56127 Pisa, Italy.

Fabrizio Maggi (F)

Virology Unit, Pisa University Hospital, Pisa, Italy; Retrovirus Center and Virology Section, Department of Translational Medicine, University of Pisa, Via del Brennero 2, I-56127 Pisa, Italy.

Paola Mazzetti (P)

Virology Unit, Pisa University Hospital, Pisa, Italy; Retrovirus Center and Virology Section, Department of Translational Medicine, University of Pisa, Via del Brennero 2, I-56127 Pisa, Italy.

Mauro Pistello (M)

Virology Unit, Pisa University Hospital, Pisa, Italy; Retrovirus Center and Virology Section, Department of Translational Medicine, University of Pisa, Via del Brennero 2, I-56127 Pisa, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH